TCRX
TScan Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.58 / 10
Netural
ROIV's fundamentals are rated mixed at 4.6/10. Key positives include a healthy interest-coverage ratio (15.48) and strong revenue growth (260.67% YoY). However, concerns linger over high days-sales-outstanding (72.55) and negative valuation gaps (Revenue-MV: -2.08, Cash-MV: -0.07). These factors collectively temper the bullish impact of growth and coverage metrics, resulting in a mixed fundamental stance.
Analysis Checks(5/10)
Revenue-MV
Value-2.08
Score1/3
Weight11.29%
1M Return4.24%
Value-2.08
Score1/3
Weight11.29%
1M Return4.24%
Days sales outstanding
Value72.55
Score1/3
Weight-3.09%
1M Return-1.57%
Value72.55
Score1/3
Weight-3.09%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight22.46%
1M Return8.45%
Value-0.17
Score2/3
Weight22.46%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-2.24%
1M Return-1.11%
Value15.48
Score2/3
Weight-2.24%
1M Return-1.11%
Asset-MV
Value-0.50
Score0/3
Weight16.03%
1M Return5.75%
Value-0.50
Score0/3
Weight16.03%
1M Return5.75%
Total operating revenue (YoY growth rate %)
Value260.67
Score0/3
Weight-10.40%
1M Return-6.11%
Value260.67
Score0/3
Weight-10.40%
1M Return-6.11%
Profit-MV
Value0.46
Score2/3
Weight22.44%
1M Return8.45%
Value0.46
Score2/3
Weight22.44%
1M Return8.45%
PB-ROE
Value-0.66
Score3/3
Weight30.42%
1M Return12.83%
Value-0.66
Score3/3
Weight30.42%
1M Return12.83%
Operating revenue (YoY growth rate %)
Value260.67
Score0/3
Weight-8.96%
1M Return-5.06%
Value260.67
Score0/3
Weight-8.96%
1M Return-5.06%
Cash-MV
Value-0.07
Score2/3
Weight22.06%
1M Return8.41%
Value-0.07
Score2/3
Weight22.06%
1M Return8.41%
Revenue-MV
Value-2.08
Score1/3
Weight11.29%
1M Return4.24%
Value-2.08
Score1/3
Weight11.29%
1M Return4.24%
Total operating revenue (YoY growth rate %)
Value260.67
Score0/3
Weight-10.40%
1M Return-6.11%
Value260.67
Score0/3
Weight-10.40%
1M Return-6.11%
Days sales outstanding
Value72.55
Score1/3
Weight-3.09%
1M Return-1.57%
Value72.55
Score1/3
Weight-3.09%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight22.44%
1M Return8.45%
Value0.46
Score2/3
Weight22.44%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight22.46%
1M Return8.45%
Value-0.17
Score2/3
Weight22.46%
1M Return8.45%
PB-ROE
Value-0.66
Score3/3
Weight30.42%
1M Return12.83%
Value-0.66
Score3/3
Weight30.42%
1M Return12.83%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-2.24%
1M Return-1.11%
Value15.48
Score2/3
Weight-2.24%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value260.67
Score0/3
Weight-8.96%
1M Return-5.06%
Value260.67
Score0/3
Weight-8.96%
1M Return-5.06%
Asset-MV
Value-0.50
Score0/3
Weight16.03%
1M Return5.75%
Value-0.50
Score0/3
Weight16.03%
1M Return5.75%
Cash-MV
Value-0.07
Score2/3
Weight22.06%
1M Return8.41%
Value-0.07
Score2/3
Weight22.06%
1M Return8.41%
Is TCRX undervalued or overvalued?
- TCRX scores 4.58/10 on fundamentals and holds a Fair valuation at present. Backed by its -55.48% ROE, -1692.96% net margin, -0.41 P/E ratio, 0.41 P/B ratio, and -17.89% earnings growth, these metrics solidify its Netural investment rating.
